Biotech CorMatrix Cardiovascular Raises $15 Million for Heart Failure Treatment
6/15/2012 7:58:37 AM
More...
|
CorMatrix Cardiovascular Adds John Davis as Executive Vice President of Sales and Marketing
3/26/2012 10:26:40 AM
More...
|
CorMatrix Cardiovascular Receives Full IDE Approval for the Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Patients Receiving the CorMatrix ECM(R) for Pericardial Closure
11/17/2011 10:50:59 AM
More...
|
CorMatrix Cardiovascular Receives Carotid Artery Repair Indication for its CorMatrix(R) ECM(R)
10/12/2011 6:46:45 AM
More...
|
CorMatrix Cardiovascular Seeks $25 Million
6/24/2011 9:43:50 AM
More...
|
CorMatrix Cardiovascular: First Patient Enrolled in Multi-Center Clinical Trial of the CorMatrix(R) ECM(R) for Pericardial Closure to Reduce the Incidence of New Onset Postoperative Atrial Fibrillation
12/13/2010 6:22:25 AM
More...
|
Study Finds Correlation Between Pericardial Reconstruction with CorMatrix Cardiovascular ECM(TM) Technology and Reduced Risk of Postoperative Atrial Fibrillation in CABG Patients
10/25/2010 12:19:19 PM
More...
|
CorMatrix Cardiovascular ECM(TM) Receives CE Mark for Cardiac Tissue Repair
6/15/2010 10:09:15 AM
More...
|
CorMatrix Cardiovascular Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology
3/17/2010 8:30:07 AM
More...
|
CorMatrix Cardiovascular Announces First European Implants of CorMatrix(R) ECM Technology(TM)
3/6/2009 10:56:49 AM
More...
|
|